Results 21 to 30 of about 219,582 (315)

Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders

Российский кардиологический журнал, 2023
The novelty of the 2023 National Guidelines for Lipid Metabolism Disorders is presented regarding the categorization of cardiovascular risk, target and optimal levels of blood lipids, diagnosis and therapeutic approaches to the treatment of dyslipidemia.
I. V. Sergienko, M. V. Ezhov
doaj   +1 more source

Lipoprotein Metabolism [PDF]

Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
Metabolic studies of lipoproteins have yielded important insights into regulation of energy distribution as well as providing fundamental understanding of cardiovascular risk properties of different lipoproteins. Although many factors on the molecular level have the potential to impact metabolic regulation of lipids, metabolic studies provide valuable ...
openaire   +2 more sources

In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity

Journal of Lipid Research, 2000
Hepatic lipase (HL) is a key player in lipoprotein metabolism by modulating, through its lipolytic activity, the triglyceride (TG) and phospholipid content of apolipoprotein B (apoB)-containing lipoproteins and of high density lipoproteins (HDL), thereby
Alberto Zambon, Samir S. Deeb, Andre Bensadoun, Karen E. Foster, John D. Brunzell   +4 more
doaj   +1 more source

Lipid Metabolism Traits Mediate the Effect of Psoriasis on Myocardial Infarction Risk: A Two-Step Mendelian Randomization Study

Metabolites, 2023
Mendelian randomization (MR) analysis was performed to explore the effect of psoriasis on lipid metabolism traits and myocardial infarction (MI) risk and to analyze the proportion of the mediatory effect of lipid metabolism traits.
Yang Ding, Shengyi Yang, Mengjiao He, Shasha Fan, Xiaohua Tao, Wei Lu   +5 more
doaj   +1 more source

KINETIC STUDIES TO ELUCIDATE IMPAIRED METABOLISM OF TRIGLYCERIDE-RICH LIPOPROTEINS IN HUMANS

Frontiers in Physiology, 2015
To develop novel strategies for prevention and treatment of dyslipidemia, it is essential to understand the pathophysiology of dyslipoproteinemia in humans.
Martin eAdiels, Martin eAdiels, Adil eMardinoglu, Adil eMardinoglu, Marja-Riitta eTaskinen, Jan eBorén   +5 more
doaj   +1 more source

Lipoprotein(a) and Metabolic Syndrome.

Deutsches Arzteblatt international, 2022
An inverse association between lipoprotein(a) (Lp[a]) and type 2 diabetes mellitus is well documented. However, data on the association of the metabolic syndrome (MetS) with Lp(a) are sparse.Cross-sectional data for MetS and Lp(a) were available for 5743 BASE-II and SHIP-0 participants (48.7% men; age 58 [20-85] years) (BASE, Berlin Aging Study; SHIP ...
Nikolaus, Buchmann, Till, Ittermann, Ilja, Demuth, Marcello R P, Markus, Henry, Völzke, Marcus, Dörr, Nele, Friedrich, Markus M, Lerch, Raul D, Santos, Sabine, Schipf, Elisabeth, Steinhagen-Thiessen   +10 more
openaire   +1 more source

Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice1

Journal of Lipid Research, 2007
Apolipoprotein A-V (apoA-V) and apoC-III are exchangeable constituents of VLDL and HDL. ApoA-V counteracts the effect of apoC-III on triglyceride (TG) metabolism with poorly defined mechanisms.
Shen Qu, German Perdomo, Dongming Su, Fiona M. D'Souza, Neil S. Shachter, H. Henry Dong   +5 more
doaj   +1 more source

Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys

Journal of Lipid Research, 2005
The objective of this study was to demonstrate the efficacy of a novel peroxisome proliferator-activated receptor (PPAR) agonist and known PPARα and PPARδ agonists to increase HDL-cholesterol (HDL-C) in the St.
Jeanne M. Wallace, Margrit Schwarz, Peter Coward, Jonathan Houze, Janet K. Sawyer, Kathryn L. Kelley, Anne Chai, Lawrence L. Rudel   +7 more
doaj   +1 more source

Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]

Journal of Lipid Research, 2000
In this study, we created LDL receptor (LDLr) defective (WHHL) transgenic rabbits expressing human apo[a] to examine whether LDLr mediates the Lp[a] clearance from the plasma.
Jianglin Fan, Mireille Challah, Hiroaki Shimoyamada, Masashi Shiomi, Santica Marcovina, Teruo Watanabe   +5 more
doaj   +1 more source

DELP Treatment on Vision and Retinal Microcirculation in Patients With Acute Ischemic Stroke: Report of Five Cases and Literature Review

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background The delipid extracorporeal lipoprotein filter from plasma (DELP) treatment can effectively reduce blood lipid, increase blood flow, and improve neurological deficits in patients with acute ischemic stroke (AIS). However, its effect on vision and retinal microcirculation in stroke patients has never been reported.
Ning Li, Ronghua Hong, Hua You, Feiping Xu, Qingjun Zhang, Yiwen Lin, Yuting Su, Danmei Lan, Lingjing Jin, Junhui She   +9 more
wiley   +1 more source